Brian Bossetta
Senior Writer, US Policy & Regulation
After moving to New York from his hometown of New Orleans, Brian worked on the East End of Long Island covering news, politics and the military. He has since covered the diamond and jewelry industries and most recently pharmacy and healthcare. His experience also includes freelance reporting and photography contributed to the New York Times.
Brian holds a BA in history from Loyola University of New Orleans, is a die-hard Saints fan, and loves running, classical music and jazz. He lives with his wife, Caroline, in New York’s magnificent Hudson Valley.
Latest From Brian Bossetta
Two Companies, One Owner; US FDA Sends Warning Letters To Same Address For Similar Issues
Two Massachusetts-based infusion pump manufacturers with the same founder and CEO received warning letters from the US FDA for similar violations.
OTC Sales Of Hearing Aids For Mild To Moderate Loss Allowed Under US FDA Final Rule
After requirement from Congress and push from President Biden, FDA establishes regulatory category for hearing aids to allow US consumers with mild to moderate hearing loss to purchase the devices without a prescription or prior exam.
Hear Ye! Hear Ye! Hearing Aids Coming To A Store Near You
The US FDA has finally established a new regulatory category for hearing aids that will allow Americans with mild to moderate hearing loss to purchase the devices directly over the counter without a prescription or prior exam.
As Cyberattacks On Hospitals Rise, Medical Devices Are Particularly Vulnerable
A wide-ranging report on cybersecurity raises many red flags for hospital network systems, especially for connected medical devices and patient data.
Class I Recall For BD Intraosseous Infusion System
The US FDA has labelled a recall of Becton Dickinson intraosseous needle set kits, manual driver kits, and powered drivers as class I, its most severe designation.
US CDC Teams Up With ACLA To Expand Monkeypox Testing
The US CDC and major laboratories across the country are working together to scale up testing capacity for monkeypox, especially now that it has been declared a public health emergency.